Gli-1/PI3K/AKT/NF-kB pathway mediates resistance to radiation and is a target for reversion of responses in refractory acute myeloid leukemia cells.
Total body irradiation combined with chemotherapy is currently the most effective procedure as a preparative myeloablative regimen. However, resistance to radiotherapy and chemotherapy in refractory acute myeloid leukemia is associated with short-time recurrence after allogeneic hematopoietic stem cell transplantation. To address this issue, we used three cell lines, HL60, HL60/ADR (adriamycin-resistant cells), and HL60/RX (a radiation-resistant cell line established from HL60 cells), as cellular models to investigate the mechanism of the Hedgehog (Hh) signaling pathway resulting in radioresistance, and the efficacy of LDE225 (an inhibitor of the Hh pathway) to enhance radiation sensitivity. Our results indicated that HL60/RX and HL60/ADR cells showed an increased in radioresistance and elevated activity of Hh pathway proteins compared with HL60 cells (P<0.001). In addition, LDE225 significantly reduced clonogenic survival with a sensitivity enhancement ratio (SER) of 1.283 for HL60/ADR and 1.245 for HL60/RX cells. The combination of LDE225 with irradiation significantly increased radiation-induced apoptosis and expression of γ-H2AX and BAK compared with single-treatment groups in both HL60/RX and HL60/ADR cells (P<0.001). In vivo, the combination of LDE225 with irradiation exerted a significant antitumor effect compared with the control and single agents in HL60/RX- and HL60/ADR-xenografted mouse models (P<0.001). Furthermore, our data obtained from western blot and IHC analyses showed that the activation of pAKT and NF-kB was reduced by LDE225 treatment in both HL60/ADR and HL60/RX cells. This demonstrates that the Gli-1/PI3K/AKT/NF-kB pathway plays a key role in resistance to radiation, and that inhibition of the Hh pathway sensitizes cells to radiation by overcoming radioresistance.
Hematology Department, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China.
Xiaodong
X
Li
Hematology Department, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China.
Fang
F
Chen
Hematology Department, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China.
Qiuhua
Q
Zhu
Hematology Department, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China.
Bingjie
B
Ding
Hematology Department, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China.|Hematology Department, Kanghua Hospital, Dongguan 523080, Guangdong, China.
Qingxiu
Q
Zhong
Hematology Department, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China.
Kaikai
K
Huang
Hematology Department, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China.
Xuejie
X
Jiang
Hematology Department, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China.
Zhixiang
Z
Wang
Hematology Department, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China.
Changxin
C
Yin
Hematology Department, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China.
Yufeng
Y
Zhu
Hematology Department, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China.
Zhen
Z
Li
Hematology Department, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China.|Hematology Department, Kanghua Hospital, Dongguan 523080, Guangdong, China.
Fanyi
F
Meng
D000818:Animals; D045744:Cell Line, Tumor; D005260:Female; D018922:HL-60 Cells; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics / Q000378:metabolism / Q000532:radiotherapy*; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D016328:NF-kappa B / Q000378:metabolism*; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism*; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism*; D011836:Radiation Tolerance; D015398:Signal Transduction; D023041:Xenograft Model Antitumor Assays; D000071676:Zinc Finger Protein GLI1 / Q000378:metabolism*
C400551:GLI1 protein, human; D016328:NF-kappa B; D000071676:Zinc Finger Protein GLI1; D019869:Phosphatidylinositol 3-Kinases; D051057:Proto-Oncogene Proteins c-akt
Gli-1/PI3K/AKT/NF-kB; LDE225; radioresistance; refractory AML